Allosteric regulation of the binding of [3H]acetylcholine to m2 muscarinic receptors

Biochemical Pharmacology

Volumn 52, Issue 11, 1996, Pages 1767-1775

  Gnagey, Ann ^a   Ellis, John ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

acetylcholine; allosteric regulation; muscarinic receptors

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; ACETYLCHOLINE; ATROPINE; GALLAMINE; GUANINE NUCLEOTIDE; GUANOSINE DIPHOSPHATE; METHYLSCOPOLAMINE; MUSCARINIC AGENT; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OBIDOXIME; PHYSOSTIGMINE; RADIOLIGAND; RECEPTOR SUBTYPE; TACRINE;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; GENE EXPRESSION; HALF LIFE TIME; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REGULATORY MECHANISM;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ALLOSTERIC REGULATION; ANIMALS; CELL MEMBRANE; CHO CELLS; CRICETINAE; GALLAMINE TRIETHIODIDE; GALLIC ACID; N-METHYLSCOPOLAMINE; RECEPTORS, MUSCARINIC; SCOPOLAMINE DERIVATIVES;

EID: 0030582833     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00598-9     Document Type: Article

References (37)

1. 1. Hammer R, Berrie CP, Birdsall NMJ, Burgen ASB and Hulme EC, Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283: 90-92, 1980.
2. 2. Kubo T, Fukuda K, Mikami A, Maeda A, Takahashi H, Mishina M, Haga T, Haga K, Ichiyama A, Kangawa K, Kojima M, Matsuo H, Hirose T and Numa S, Cloning, sequencing, and expression of complementary DNA encoding the muscarinic acetylcholine receptors. Nature 323: 411-416, 1986.
3. 3. Kubo T, Maeda A, Sugimoto K, Akiba I, Mikami A, Takahashi H, Haga T, Ichiyama A, Kangawa K, Matsuo H, Hirose T and Numa S, Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence. FEBS Lett 209: 367-372, 1986.
4. 4. Bonner TI, Buckley NJ, Young AC and Brann MR, Identification of a family of muscarinic acetylcholine receptor genes. Science 237: 527-532, 1987.
5. 5. Bonner TI, Young AC, Brann MR and Buckley NJ, Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1: 403-410, 1988.
6. 6. Levey AI, Kitt CA, Simonds WF, Price DL and Brann MR, Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 11: 3218-3226, 1991.
7. 7. Maeda A, Kubo T, Mishina M and Numa S, Tissue distribution of mRNAs encoding muscarinic acetylcholine receptor subtypes. FEBS Lett 329: 339-342, 1988.
8. 8. Jones SVP, Weiner DM, Levey AI, Ellis J, Novotny E, Yu S-H, Dorje SF, Wess J and Brann MR, Muscarinic acetylcholine receptors. In: Molecular Biology of G-Protein-Coupled Receptors (Ed. Brann MR), pp. 170-197. Birkhauser, Boston, 1992.
9. 9. Ellis J, Huyler J, and Brann MR, Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes. Biochem Pharmacol 42: 1927-1932, 1991.
10. 4) in rat forebrain Mol Pharmacol 38: 267-273, 1990.
11. 11. Lee NH and El-Fakahany EE, Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem Pharmacol 42: 199-205, 1991.
12. 12. Clark AL and Mitchelson F, The inhibitory effect of gallamine on muscarinic receptors. Br J Pharmacol 58: 323-331, 1976.
13. 13. Waelbroeck M, Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors. Mol Pharmacol 46: 685-692, 1994.
14. 14. Ellis J and Seidenberg M, Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol Pharmacol 42: 638-641, 1992.
15. 15. Lee NH, Jingru H and El-Fakahany EE, Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor. J Pharmacol Exp Ther 262: 312-316, 1992.
16. 16. Ellis J, Seidenberg M and Brann MR, Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. Mol Pharmacol 44: 583-588, 1993.
17. 17. Leppik RA, Miller RC, Eck M and Paquet J-L, Role of acidic amino acids in the allosteric modulation by gallamine of antagonist biding at the m2 muscarinic acetylcholine receptor. Mol Pharmacol 45: 983-990, 1994.
18. 18. Matsui H, Lazareno S and Birdsall NJM, Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. Mol Pharmacol 47: 88-98, 1995.
19. 19. Lee NH and El-Fakahany EE, Allosteric interactions at the m1, m2, and m3 muscarinic receptor subtypes. J Pharmacol Exp Ther 256: 468-479, 1991.
20. 20. Buckley NJ, Bonner TI, Buckley CM and Brann MR, Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35: 469-476, 1989.
21. 21. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ, Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
22. 1-adrenergic response. J Neurochem 50: 558-564, 1988.
23. 23. Younkin SG, Rosenstein C, Collins PL and Rosenberry TL, Cellular localization of the molecular forms of acetylcholinesterase in rat diaphragm. J Biol Chem 257: 13630-13637, 1982.
24. 24. Berrie CP, Birdsall NJM, Burgen ASV and Hulme EC, Guanine nucleotides modulate muscarinic receptor binding in the heart. Biochem Biophys Res Commun 87: 1000-1006, 1979.
25. 25. Harden TK, Scheer AG and Smith MM, Differential modification of the interaction of cardiac muscarinic cholinergic and beta-adrenergic receptors with a guanine nucleotide binding component(s). Mol Pharmacol 21: 570-580, 1982.
26. 26. Kurose H, Katada T, Amano T and Ui M, Specific uncoupling by islet activating protein, pertussis toxin, of negative signal transduction via α-adrenergic, cholinergic, and opiate receptors in neuroblastoma and glioma hybrid cells. J Biol Chem 258: 4870-4875, 1983.
27. 3H]acetylcholine to muscarinic cholinergic receptors. J Neurosci 5: 1577-1582, 1984.
28. 3H]acetylcholine to muscarinic receptors. Regional distribution and modulation by guanine nucleotides. Mol Pharmacol 28: 297-305, 1985.
29. 29. Mattera R, Pitts BJR, Entman ML and Birnbaumer L, Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. J Biol Chem 260: 7410-7421, 1985.
30. 30. Stockton JM, Birdsall NJM, Burgen ASV and Hulme EC, Modification of the binding properties of muscarinic receptors by gallamine. Mol Pharmacol 23: 551-557, 1983.
31. 31. Proska J and Tucek S, Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. Mol Pharmacol 45: 709-717, 1994.
32. 32. Lazareno S and Birdsall NJM, Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: Interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 48: 362-378, 1995.
33. 33. Ellis J and Seidenberg M, Gallamine exerts biphasic allosteric effects at muscarinic receptors. Mol Pharmacol 35: 173-176, 1989.
34. 34. Tucek SL, Musilkova J, Hedoma J, Proska J, Shelkovnikov S and Vorlicek J, Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors. Mol Pharmacol 38: 674-680, 1990.
35. 35. Potter LT, Ferrendelli CA, Hanchett HE, Hollifield MA and Lorenzi MV, Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarinic receptors. Mol Pharmacol 35: 652-660, 1989.
36. 36. Hirschberg BT and Schimerlik MI, A kinetic model for oxotremorine-M binding to recombinant porcine m2 muscarinic receptors expressed in Chinese hamster ovary cells. J Biol Chem 269: 26127-26135, 1994.
37. 37. Wreggett KA and Wells JW, Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors. J Biol Chem 270: 22488-22499, 1995.